Staged surgical approach of neonates with esophageal atresia and tracheoesophageal fistula from low- and middle-income countries
link.springer.com shows its articles on its own site.
Read the article on link.springer.com ↗Article · Dec 2022 · 1 min read
In brief
In brief
This study demonstrates successful outcomes for neonates with EA/TEF from low- and middle-income countries using a staged approach with initial gastrostomy placement locally, followed by definitive repair in the U.S. through World Pediatric Project partnership. Results matched U.S.-born patients with the same condition, showing feasibility of international collaboration for complex neonatal surgical care.
Written by the GCMD Library team from the article.
Abstract
Background
Neonates born in low- and middle-income countries (LMICs) with esophageal atresia (EA) and tracheoesophageal fistula (TEF) often do not have access to adequate surgical care. We have partnered with the non-profit organization World Pediatric Project (WPP) to facilitate care for such patients.
Methods
Our protocol included placement of a gastrostomy tube by local surgeons before definitive repair at the Children’s Hospital of Richmond at VCU (CHoR). The outcomes of WPP-sponsored patients with EA and TEF in this program (n = 9) were compared to patients born in the U.S. with the same condition at CHoR (n = 9).
Results
The baseline characteristics of the groups aside from the age at admission to CHoR and at day of surgery were comparable (0.5 ± 1.3 days vs. 15.3 ± 11.1 days, p < 0.0001; 1.1 ± 3.9 days vs. 37.3 ± 8.3 days, p < 0.0001, respectively). All patients received definitive repair without mortality; the average length of stay after surgery was lower in the WPP group. There were 4 surgical complications in the U.S. group and 1 in WPP group. All patients were weaned off of TPN and all WPP patients are now on a regular PO diet. Every WPP patient has been seen in follow-up in the U.S. and in their home country.
Conclusion
We provided successful multidisciplinary care for neonates with EA and TEF from LMICs with outcomes similar to the neonates with the same abnormality in the U.S. The partnership with WPP has been invaluable as it has provided essential support to identify and manage these patients.
Level of evidence
IV.